异福酰胺片(Ⅱ)人体生物等效性评价  被引量:2

Bioequivalence study on Yifuxianan tablets (Ⅱ) in healthy volunteers

在线阅读下载全文

作  者:井亚坤[1] 冷东伟[2] 赵云丽[1] 张国顺[1] 于治国[1] 

机构地区:[1]沈阳药科大学药学院,辽宁沈阳110016 [2]大连医科大学附属第二医院药剂科,辽宁大连116027

出  处:《沈阳药科大学学报》2011年第6期477-482,共6页Journal of Shenyang Pharmaceutical University

摘  要:目的研究20名健康志愿者单剂量经口给予异福酰胺片(Ⅱ)受试制剂和参比制剂后的人体生物等效性。方法采用反相高效液相色谱法分别测定给药后受试者血浆中利福平、异烟肼、吡嗪酰胺3种有效成分的质量浓度,用DAS软件求其药动学参数及相对生物利用度。结果利福平、异烟肼、吡嗪酰胺的线性范围分别为0.40~25.0 mg·L-1、0.10~10.0 mg·L-1、0.30~60.0 mg·L-1,相关系数均大于0.99,日内和日间精密度均小于15%,提取回收率均大于70%,受试制剂中利福平、异烟肼、吡嗪酰胺的相对生物利用度分别为(97.5±25.5)%、(108.7±24.0)%、(109.0±17.4)%。结论受试制剂与参比制剂生物等效。Objective To study the bioequivalence of Yifuxianan tablets(II)(compound preparation of rifampicin,isoniazid and pyrazinamide) after a single oral dose of the tested and referred preparations to 20 healthy volunteers.Methods Concentrations of rifampicin,isoniazid and pyrazinamide in plasma were determined by RP-HPLC,pharmacokinetic parameters and relative bioavailability were calculated by using DAS software.Results The linear ranges of rifampicin,isoniazid and pyrazinamide were 0.40-25.0 mg · L-1,0.10-10.0 mg · L-1 and 0.30-60.0 mg · L-1,with good linearity(r0.99),intra-and inter-day precisions were below 15%,average recoveries of three drugs were above 70%,the relative bioavailability of rifampicin,isoniazid and pyrazinamide were(97.5±25.5)%,(108.7±24.0)% and(109.0±17.4)%,respectively.Conclusions The tested preparation is bioequivalent with the referred preparation.

关 键 词:异福酰胺片(Ⅱ) 利福平 异烟肼 吡嗪酰胺 高效液相色谱法 生物等效性 

分 类 号:R97[医药卫生—药品]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象